LncTAC Biotechnology Co., Ltd.
PrivateLast Round
Series A
Jun 26, 2026
Total Funding Raised
$44.25M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
LncTAC Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series A round in June 2026.
LncTAC Biotechnology Co., Ltd. is a biotechnology company that develops lncRNA-based therapeutic drugs and delivery technology platforms for oncology, central nervous system disorders, and dermatology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LncTAC Biotechnology Co., Ltd. Comparables
Compare LncTAC Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 水木星辰生物制药(深圳)有限公司 | 83% | |
| HAYA Therapeutics | 79% | |
| Vivatides Therapeutics | 77% |
For institutional investors. Book with your work email.
LncTAC Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 26, 2026 | ||||
| VC Round | Oct 26, 2023 |
For institutional investors. Book with your work email.
LncTAC Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | Series A |
| Legend Capital | Series A, VC Round |
| Sunshine Riverhead Capital Investment Management Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
$44.25M round led by Lapam Capital.
- Oct 26, 2023
$14M round led by Legend Capital
For institutional investors. Book with your work email.
LncTAC Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LncTAC Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is LncTAC Biotechnology Co., Ltd. a public or private company?
LncTAC Biotechnology Co., Ltd. is a private company.
What is the current stock price of LncTAC Biotechnology Co., Ltd.?
LncTAC Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks LncTAC Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LncTAC Biotechnology Co., Ltd. worth (valuation)?
Valuation information for LncTAC Biotechnology Co., Ltd. is not publicly available.
Can I buy LncTAC Biotechnology Co., Ltd. stock?
LncTAC Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LncTAC Biotechnology Co., Ltd.'s last funding round?
LncTAC Biotechnology Co., Ltd.'s most recent funding round was Series A on June 26, 2026.
Who are the main investors in LncTAC Biotechnology Co., Ltd.?
Key investors in LncTAC Biotechnology Co., Ltd. include Lapam Capital, Legend Capital.
Will LncTAC Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for LncTAC Biotechnology Co., Ltd..
How can I track LncTAC Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in LncTAC Biotechnology Co., Ltd.'s shares on secondary markets.